Medical Properties Trust (MPT) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.01
- Estimate
- —
- Surprise
- —
- Score at report (before → after)
- 5.9 → 6.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
TrendMatrix's engine moved from Sell (5.9/10) to Hold at 6.1/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MPT Sell at 5.7/10.
1 of the last 4 quarters beat the estimate. Next scheduled report: 2026-10-29.
What supports the rating
- Attractive valuation
- Analyst upside: 24%
What argues against it
- Sector modifier (Real Estate): -1.2
- Leverage penalty (D/E 2.2): -1.5
- Elevated risk factors
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $3.60
- Price target
- $4.46
- Stop
- $3.35
- Upside to target
- +23.9%
- Reward-to-risk
- 2.9:1
Model outputs from TrendMatrix’s engine as of 2026-09-24 — shown for context, not personalized investment advice.
MPT at TrendMatrix's latest read
REIT quarters hinge on occupancy, rate exposure, and FFO rather than headline EPS, which mechanically distorts under depreciation.
- Industry
- REIT - Healthcare Facilities
- Market cap
- $2.14B
- P/E (fwd)
- 71.8
- 52-week range
- $3.36–$6.47
- Off 52-week high
- 44.4%
- RSI (14)
- 37
- Volume vs avg
- 0.80×
- Score today
- 5.7/10